NovoCure (NVCR) Exchange Rate Effect (2016 - 2026)
NovoCure (NVCR) posted quarterly Exchange Rate Effect of -$8000.0 for Q2 2026, down 103.02% year-on-year from $265000.0 in Q2 2025, and up 93.85% on a QoQ basis from -$130000.0 in Q1 2026.
NovoCure (NVCR) Exchange Rate Effect (2016 - 2026) Analysis & Trends
NovoCure (NVCR) has reported Exchange Rate Effect for 11 consecutive years, with -$8000.0 the latest figure, recorded in Q2 2026.
- Quarterly Exchange Rate Effect fell 103.02% year-over-year to -$8000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$236000.0 (down 152.33% YoY) and the FY2025 annual result came in at $394000.0, up 326.44% from the prior year.
- Exchange Rate Effect improved to -$8000.0 in Q2 2026 per NVCR's latest filing, from -$130000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for NVCR reached as high as $265000.0 in Q2 2025 and fell as low as -$130000.0 in Q1 2026.
- A 5-year average of $6444.4 and a median of -$23500.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect sank 3900.0% — and 2025, when it surged 505.36%.
- Year by year, Exchange Rate Effect stood at $155000.0 in 2022, then rose by 29.03% to $200000.0 in 2023, then sank by 164.0% to -$128000.0 in 2024, then soared by 40.62% to -$76000.0 in 2025, then soared by 89.47% to -$8000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$8000.0, -$130000.0, and -$76000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 33.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -2.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.66 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -37.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NovoCure | 2.28 Bn | 1.85 Bn | 142.48 Mn | -8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8,000.00 |
| Jun 30, 2026 | -8,000.00 |
| Mar 31, 2026 | -130,000.00 |
| Mar 31, 2026 | -130,000.00 |
| Dec 31, 2025 | -76,000.00 |
| Dec 31, 2025 | -76,000.00 |
| Sep 30, 2025 | -22,000.00 |
| Sep 30, 2025 | -22,000.00 |
| Jun 30, 2025 | 265,000.00 |
| Jun 30, 2025 | 265,000.00 |
| Mar 31, 2025 | 227,000.00 |
| Mar 31, 2025 | 227,000.00 |
| Dec 31, 2024 | -128,000.00 |
| Dec 31, 2024 | -128,000.00 |
| Sep 30, 2024 | 87,000.00 |
| Sep 30, 2024 | 87,000.00 |
| Jun 30, 2024 | -77,000.00 |
| Jun 30, 2024 | -77,000.00 |
| Mar 31, 2024 | -56,000.00 |
| Mar 31, 2024 | -56,000.00 |